z-logo
open-access-imgOpen Access
Late onset pityriasis rubra pilaris type IV treated with low-dose acitretin
Author(s) -
Fernando Mota,
Sandrina Carvalho,
Madalena Sanches,
Manuela Selores
Publication year - 2016
Publication title -
acta dermatovenerologica alpina pannonica et adriatica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.376
H-Index - 28
eISSN - 1581-2979
pISSN - 1318-4458
DOI - 10.15570/actaapa.2016.4
Subject(s) - pityriasis rubra pilaris , acitretin , palmoplantar keratoderma , dermatology , medicine , acanthosis , hyperkeratosis , dyskeratosis , family history , surgery , psoriasis
Pityriasis rubra pilaris is a chronic inflammatory dermatosis of unknown etiology and great clinical variability. It has been divided into six categories. Types III, IV, and V occur in childhood and are distinguished by their clinical presentation, age of onset, and course. We report a 19-year-old male patient with a 2-week history of pruritic, scaling dermatosis of the hands, feet, elbows, and knees. He had no family history of skin disease. On physical examination, we observed circumscribed, reddish-orange, scaling plaques affecting the elbows and knees and a waxy palmoplantar keratoderma. The skin biopsy showed acanthosis, alternating orthokeratosis, parakeratosis, and follicular plugging suggestive of pityriasis rubra pilaris. The patient started treatment with oral acitretin, 25 mg every other day. The treatment was tolerated well, and after 6 months the lesions had resolved completely. Pityriasis rubra pilaris is a chronic papulosquamous disorder of unknown pathogenesis, characterized by reddish-orange scaly plaques, palmoplantar keratoderma, and keratotic follicular papules. There is still no consensus regarding the treatment, but therapeutic options include systemic retinoids, particularly acitretin in the recommended dose of 0.5 to 0.75 mg/kg/day. In our case, the patient was treated with a low-dose regimen of acitretin, which was effective and well tolerated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom